Atıf İçin Kopyala
Icli F., ÇELİK İ., Aykan F., Uner A., DEMİRKAZIK A., Ozet A., ...Daha Fazla
CANCER, cilt.83, sa.12, ss.2475-2480, 1998 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
83
Sayı:
12
-
Basım Tarihi:
1998
-
Dergi Adı:
CANCER
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.2475-2480
-
Anahtar Kelimeler:
advanced gastric carcinoma, cisplatin, epirubicin, etoposide, 5-fluorouracil, randomized controlled trial, CANCER, DOXORUBICIN, COMBINATION, FLUOROURACIL, CHEMOTHERAPY, ADRIAMYCIN, MITOMYCIN, REGIMENS, CELLS
-
Ankara Üniversitesi Adresli:
Evet
Özet
BACKGROUND, Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with advanced gastric carcinoma (AGC)